Stoke Therapeutics Inc buy Chardan Capital
Start price
20.12.24
/
50%
€10.70
Target price
20.12.25
€23.06
Performance (%)
148.60%
Price
11:12
€26.60
Summary
This prediction is currently active. With a performance of 148.60% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 20.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 21.495% | 21.495% |
| iShares Core DAX® | -0.693% | 2.143% |
| iShares Nasdaq 100 | -1.173% | 1.632% |
| iShares Nikkei 225® | -1.388% | 2.138% |
| iShares S&P 500 | -1.411% | 0.648% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
92.75%
11:12
11:12
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
197.21%
11:12
11:12